|
FDA Concerned About OTC Asthma Treatment
Monthly Prescribing Reference Multiple adverse event reports have prompted the FDA to issue a warning about the use of Asthmanefrin (racepinephrine; Nephron) and the EZ Breathe Atomizer. Asthmanefrin is an over-the-counter product indicated for the temporary relief of mild symptoms … |
View full post on asthma – Google News